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We here tl¢~erib~ the ~:l¢~nlnj ot' an additional ltene, called h-I,l~, ~thid~ is ~imilar 1o the pr~vious|y cloned hua~n ~.adr~nerlfie re~:eptor located 
on ehromo~onne 4, The ~;.I.1~ Ilene wa~ identified h~ u~tnl! the pol)tm~ra~e chitin reaction with pdmer~ 1~¢111¢ For ,etlUenee~ in transmemhran¢ 
re|lion~ 2 and :~ of tl~e previously i~olated human ~.¢'4 at~d "h.CI0 adr~n~ep~or Ilenes, which are ioeallxed onehr~mo~om~ 4 a~d 10, re,l~¢tivel~, 
The new ~ene w~x identified by t~mplifyinlt the I>1 kh ~iz~ fractionated r,~ion of P~tl re,Friction cut human l~enomi¢ DNA, The previously don~d 
,~tcCI0 and ~.C4 g~ne~ were re~:overed at their expected Iocadon~. 0,96 and 5,9 kh, r¢~i'.~ctlvdy, We have id~nlifi~d 387 ba~e~ of the new ~.  I,~ 
I~ene, and its ~<quenee i~ identical io the previoufl~, de.r i led ~.C4 ~en¢, ht|! i~ all,liner From lhe ¢tz,CIO and =~.C2 llenes, Our r¢~ult~ demonstrat~ 
thai the ~.C'4 adrenerBie recap|or exi~t~ in more than on~ eop~ in the I~uman Ilenome, 
=~-Adren~rtti~: reeeptor; Two copy jan~: Polymerase chain r~acllon 
1, INTRODUCTION 
The diversity of catecholamine effects arc mediated 
by proliferating a multitude of receptors which all 
belong to a superfamily of G-protein coupled receptors 
[1]. The catecholamine r ceptors have previously been 
classified according to pharmacological criteria into 
several types such as at, an,/~t, B2, Dt and D2 [2-4]. 
These receptors elicit their responses by coupling to 
membrane bound G.protein which regulate the activity 
of different cellular effectors, For example, a distinct 
G-protein links /3-adrenoceptors in a stimulatory 
fashion to adenylate cyclase so that stimulation of the 
/3-adrenoceptor will lead to increased formation of  
cAMP. Other examples are ~-adrenoceptors wl~ich 
mediate breakdown of phospholipids by activating 
specific phospholipases via G.protein linked pathways 
[5]. Recently, gene cloning techniques have revealed 
that there exist many more distinct genes coding for 
catecholamine receptors than were initially assumed 
from the pharmacological classifications. For example, 
in humans distinct genes coding for 3 different ~- 
adrenoceptors [6"8], 3 different c~2-adrenoceptors 
[9'11] and 2 dopamine receptors [12,13] have been 
identified, The three c~z-adrenergic receptors have been 
named c~z-C2, uz-C4 and a2-Cl0 due to their location 
on chromosomes 2, 4 and 10 of the human genuine, 
These genes may be identified in Southern blot analysis 
of PstI cut DNA as bands at 1.6, 5.9 and 0.95 kb [9,11] 
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and their sequences are distinct albeit with grea.t 
homologies. 
All adrcnergic receptors how amino acid sequence 
patterns common to all other G-protein coupled recep- 
tors which is consistent with a topology of the receptor 
proteins spanning the cell membrane 7 times, 
Moreover, the membrane spanning regions show the 
310,  
Fig. 1, Ethidium bromide.stained agarose gel showing PCR amplified 
products obtained by using size fractionated Pstl cut DNA and 
primers designed from conserved nucleotide sequences ncoding the 
2nd and 5th transn~embrane regions of  human a2-C4 and a2-CIO 
adrenoceptor genes, Shown are products obtained from DNA 
fragments of 0.96 kb (lane 1), 1,8 kb (lane 2), 5,9 kb (lane 3) and 3.5 
kb (lane 4), Lane 5 shows Ox174/Haelll standard fragments, 
Published by Elsevier Science Publishers B. K 241 
Volume 280, number 2 FEBS LETTERS 
greatest seq,eace similarities which ha~ made i~ possible 
to clone additional memb¢|'s of the G-protein coupled 
receptor family by using homologous primers in the 
PCR [14], Using PCR we now r~port the Iderttil'icaflo. 
of an add i t iona l  human c ,=-adrenoceptor  =ene wh ich  is 
similar to the ct.,-adrenoceptor gene previously cloned 
from kidney eDNA and found to be located on 
chromosome 4 [10], 
2. MATERIALS  AND METHODS 
2, I, Oli~o*.~¢l¢.tM¢s 
TI,~ Oli~Ol%U~l{Olld¢ plqmer~, g~¢d ~¢r¢ ~p¢¢iI'i¢ for  ih¢ preciously 
*;lCncd . r¢ '4  ~.d  * t r¢  It] aud destined fro, .  zh¢ir m~:mbra~¢ H~n.  
flMl~ ~m~l .~ .~ a .d  $ a .d  wiwlcd  rr~m~ r¢~lonv~ I i.# idcr.lcal for 
bolh  r¢¢¢ptor~. The primer~ were do, i i l .<d whh ro l r i¢ f lon  en, 
dom~¢lea~e Ih~k~r~ E~'uRi ~fld ltamFll at ~1~¢ ~ eneh ~o fa~ilii~lttl 
~l~.i . l¢ o f  ctmpltricd I'ragllt~hl~: 
Alpha-2  ¢~ a A ~ | L ¥ A ~ L | ~ P F ~ L A N ~ L L G Y W ¥ ~ ~ R 
A |ph~=2 C2 G~C GCC GAC A~¢ C~G G~G G~C NCG C~¢ ACe A~ CC~ ~¢¢ ~G ¢~¢ G¢~ AA¢ GAG C'~G ¢~G G~¢ ~AC eGG TAC ~¢ CG~ ¢G¢ 
A lpha-2  l ,~  5 A D : ~. v A ~ L V M P F ~ L A N ~ L H A Y W Y F G O 
A~pha =]  l .S  ¢CG GCC GAC A~¢ C~ GTG GCC &C~ CTG G~C AT~ ¢Ct ~¢ ~CO ¢ I~ GC¢ AAC GAO ¢~C A~G GCC ~AC eGG TAC ~¢ GG~ CAG 
A lpha-2  5 ,9  s A D ~ L V A ; i V M P F $ k A H g L H A ¥ W Y Y G Q 
A |pha-2  $ ,~ TCG GCC GAC ATe C~G GIG ~CC A¢G CTG G~C A~G ¢C¢ 7~¢ ~CG ~G GC¢ AA¢ ~AG CT¢ A~G GCC ~AC TGG TAC ~T¢ G6G CA~ 
AIph~-2 0,96 $ A D ! L V A ~ b V I P F ~ ~ A N R V H G ~ W ¥ F 0 M 
Alpha-2  0 ,96  TCC CCC GAC ~;~ ~ C~ ~C~ AC~ ~TC G~C A~C CC~ ~C ~CG CTG OCC AAC GAG GT~ A~G GGC ~AC ¢GG: TAC ~ GG~ K,%G 
Pr imer  I 
I I I  
Alpha-2  C2 T w C K V Y L A L D V L ~ C T S $ ! V H L C A I 5 b D 
A lpha-2  C2 ACG ~GG TGC GAG G~G TAC CTG GCG CTC GAC G~G ¢7C 7T¢ TGC ACC TCG TCC ATC GTG CAC C~G TGC GCC ATC AGC CTG GA¢ 
A l~ha-2  1,8 V W C G V ¥ L A L m V L F C T S 5 ! V H L C A | S L D 
Alpha-2 1,8 GTG TGG TGC GGC GTG TAC ¢TG GCG CTC GAT G~G ¢¢0 TTT ~GC ACC ~CG TCG ATC GTG CAT C~0 ~GT GCC ATC AGC CTG GAC 
Alpha-2 5.9 u w C G v ~ L A L O V i F C T S S | V )I L C A l S b D 
A*pha'2 5.9  GTG TGG ~GC GGC GTG TAt  CTG GCG CTC SAT G~G C~G eTT ~GC Ace ~CG ¢CG ATe G$G CAT C¢G ~GT GCC ~¢C AGe C~G SAC 
A lpha-2  0 .96  r~ w c K ! ~ b h L O v L r C T S S I V H [~ C A I S b O 
A~pha=2 0.~6 GeT ~GG TGC GAG ATe The CTG GCG CTC GAC GTG C~C ~TC ~GC ACG TCG TCC ATe G~G CAC CCO ~GC GCC ATe AGe CTG GAC 
Iv 
Alpha-2 C2 R Y W ~ V S R h L E Y N s K R ~ ~ R B X K C I I L T V 
Mpha-2  C2 CGC TAC TGG GCC GTG AGe CGC GCG CTG GAG TAC AAC ~CC AAG CGC ACt CCG CGC CGC ATe hAG TGC ATe KTC CTC ACT GTG 
A~pha-2 1,8 R Y W S V T Q A V ~ y N L K R T P R R v K A T ! V ~ V 
Alpha-2 1.8 CGC TAC TGG TCG GTG ACG CAG GCC GTC GAG TAC AAC CTG AAG CGA ACA CCA CGC CGC GTC KAG GCC ACC ~TC GTG GCC GTG 
Alpha-2 5.9 R Y W s v T O k V E Y N L K R T P R R V K A T l V A V 
Alpha-2 5.9 CGC TAC TGG TCG GTG ACG CAG GCC GTC GAG TAC AAC CTG AAG CGA ACA CCA CGC CGC GTC hAG GCC Ace ATC GTG GCC GTG 
Alpha-2 0,96 R Y W S I T Q ~ I E Y N L K R T P R R I ~ A I I I T 
Alpha-2 0.96 CGC TAC TGG TCC ATe ACA CAG GCC ATC GAG TAC AAC CTG AAG CGC ACG CCG CGC CGC ATC hAG GCC ATC ATe ATe Ace GTG 
Alpha-2 C2 W L I A A V Z S L P P L I Y K G D Q G P Q p R G 
Alpha-2 C2 TOG CTC ATe GCC GCC GTC ~TC TCG CTG CCG CCC CTC ATC TAC AAG GGC GAC CAG GGC CCC CAG CCG CGC GGG 
Alpha-2 1.8 W L I S A V Z S F P P L V S L Y R Q P D G A A Y 
Alpha-2 ).8 TOG CTC ATC TCG GCC GTC ATe TCC TTC CCG CCG CTG GTC TCG CTC TAC CGC CAG CCC GACGGC GCC GCC TAC - - - 
Alpha-2 5.9 N L I S A V I 5 F P P L V S L Y R Q P D G A A Y 
Alpha-2 5.9 ~GG CTC ATe 7CG GCC GTC ATe TCC TTC CCG CCG CTG GTC TCG CTC TAC CGC CAG CCC GAC GGC Gee GCC TAC - 
Alpha-2 0.96 W V I S A V I S F P P L I S ~ E K K G G G G G P Q p A 
Alpha-2 0,96 TGG GTC ATe TCG GCC OTC ATC TCC TTC CCG CCG CTC ATC TCC ATC GAG AAG hAG GGC GGC GGC GGC GGC CCG CAG CCG GCC 
Alpha-2 C2 R P Q C K L N Q E A W Y I L A s S I G S F F A P C 
Alpha-2 C2 CGC CCC CAG TGC AAG CTC AAC C~G GAG GCC T~G TAC ATC CTG GCC TCC AGC ATC GGA TCT TTC TTT GCT CCT TGC 390 bp 
Alpha-2 1.8 P Q C G L N D E T W Y I L s S C I G S F F A P C 
Alpha-2 1.8 CCG CAG TGC GGC CTC AAC G~C GAG ACC TGG TAC ATC CTG TCC TCC TGC ATC GGC TCC 'fTC TTC GCT CCC TGC 387 bp 
Alpha-2 5.9 P Q C G L N D E T W Y I L S S C I G S F F A P C 
Alpha-2 5.9 CCG CAG TGC GGC CTC AAC GAC GAG ACC TGG TAC ATC CTG ~CC TCC TGC ATC GGC TCC TTC TTC GCT CCC TGC 387 bp 
Alpha-2 0.96 E p R C E I N D Q K W Y V I S S C I G S F F A P C 
Alpha-2 0.96 GAG CCG CGC TGC GAG ATC AAC GAC CAG AAG TGG TAC GTC ATC ~CG TCG ~GC ATC GGC TCC TTC TTC OCT CCC TC~ 399 bP 
Pr imer 2 
Fig, 2, Alignment of the nucleotide and deduced amino acid sequences for c~2-C2 as well as the PCR Products obtained from 1,8 (c~2.1,8), 5,9 
(t~z-5.9) and 0,96 (t~.0.96) kb DNA. The DNA sequence of c~2-5,9 iscompletely identical to the published sequence of a2-C4 [10]. The sequence 
of u2-0,96 is identical to the published sequence of t~2-CI0 [l 1], except for three amino acids marked witl~ boxes. These differences cannot be at- 
tributed to PCR-artifacts as we have observed them in 2 completely different experiments, Sequences representing membranes spanning membranes 
l l -V are marked with bars above sequence, Tl~e underlined sequences indicate primer 1 and 2 used for the PC R, Gaps, sllown as dashes, are inserted 
to maximize homologies, 
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Vulum¢ ~.~0, number ~ FE[ .~ LETTERS M~rch 1~19I 
Pr|at<r I : 
A¢~ ¢~¢. I r-truer 
¢,AT£,¢. A 
(: c etA^ rrc ¢,¢~c c c~^ c A re ~ rc, G r¢~¢,c, 
2: CCG(iATC¢'AG¢~GA GCCtA A(t,~AGGA(3C" 
2.~. I=~11 ¢lig¢~tiun, eHnptifi¢~lion, ¢lotlillx uml ~¢~tll¢liehlJ[ 
thl¢ ~ ~f human t~enomI¢ DNA vm~ ¢u1 IO completion ~hh/~,~11 
aud d¢~lrt~pl~or~wd on I~  at~at~w 1~¢1, The band., al die po~|ll,~n.~ 
0.96 kb, I,a kb, ~t.$ kh and $.~ kb ~-¢¢e u! and exlra~gled u~lltl~ 
Ck'lt¢,gleall (BtO 101, USA}. The ehlled DNA wa,~ ¢lq on¢¢ It=Ilia with 
P~¢I ¢le~lr,dplior~ted ~,tabove, and bcmd~ ts¢l~e¢l from r~l~i i lve  
pO~tlion~ lind I1~¢ 13NA g,'~l r l,gl~¢i| |l~il~t[ Get~edeitn. Two ¢y~:1¢~ of I>Jll 
tltll¢~lioo ,'tnd el¢~;lroptture~l~ were pclrtorrned In o,'d,~r Io cn~ilr¢ 1h¢ 
exact li~¢ =1" the t)NA. 
Alt(lUOl~ Of the ab~.~v¢ prepared ~t~¢~ rra,:tiouated I~NA ~ample'~ 
~¢r¢ ,~tlbje~tetl Io PCR u~i1111 lh¢ abo~,c.mtntloned prinl~r~, The PCR 
war perl'0rl'tted with (belie Alup I)NA a~llpltti¢~liOn realeftl kit [tom 
Perkin EIw~¢r t~ot p., USA anti Hie lh~rmal profil~ 115¢tl ~ax 9~I*C = 30 
~ I; 9.1~'C " - 3t1~, 60 C - 3fl.. 7~-~C = 40 ~t x ~10; "/'~'C = $ rain 
I. Twenly percent of ~:a¢l~ PCR ~lltpl¢ w;t~ analyzed bx ~1¢~. 
tropltorcsis as shown in l;il~, I, The rest Or the real trial was tlstd rot 
liillttlnl11111o PGEM 7Z r ( =,. ) v¢~:lor lind Silb~¢qlli3ll .wquen¢Inll u~inl~ 
1h¢ dideosy chain lermlnalion mctllod [1~], 
3, RESULTS AND DISCUSSION 
Oligonucleotides which represented conserved 
nucleotide sequences encoding the 2nd and Sth 
transmembrane r gions of human t~2-C4 and t~z.ClC 
adrenoceptor genes were used as primers in amplifica. 
tion of PstI cut size fractionated human genomic DNA, 
Using this approach we amplified 387 bp of the c12.C4 
gene from 5.9 kb DNA fragments (a..-5,9), as well as 
399 bp af  thea2-Cl0 gene t'rom 0.96 kb DNA fragments 
(a~-0.96) (Figs 1 and 2). These results are fully consis- 
tent with previously published sequence and Southern 
blot data for cca-adrenoceptor genes [10,11], The new 
c¢z-1.8 gene (387 bp) was amplified from 1,8 kb DNA 
fragment and its seqaence was found to be identical to 
the c¢2-C4 gene (Figs 1 and 2), In order to ensure that the 
new gene was not a product of carryover from the 5.9 
kb fragment hat had not been fully separated on the 
agarosu gel, the Pstl digestion and electrophoresis of
DNA was repeated twice before performing the PCR, 
Moreover, the DNA of 3.5 kb fragments, which is ex- 
pected to be a non-specific region for a2-adrenoceptors, 
did not yield any PCR products (Fig, 1), Furthermore, 
the whole experiment was repeated twice starting from 
genomic DNA and identical sequencing results were ob- 
tained in both experiments. The reason that we in the 
present study were unable to identify the u2-C2 gene 
that was recently described [9] isthat there is a single 
base mismatch at the 3' end of primer 2 used in this 
study, as compared to the u2-C2 sequence, 
The new c~2-1,8 gene shows distinct sequence dif- 
ferences with the a2-C10 and az-C2 genes, but has 
almost identical sequence to the ~2-C4 gene (Fig. 2), 
The az.C4 gene has been previously cloned from human 
kidney eDNA. This gene was said to be localized on 
chromosome 4 and a 5.9 kb fragment of PstI cut human 
genomic DNA [10]. The t~z-l.8 gene is localized on the 
1,8 kb fragments of PstI cut human DNA and it shows 
~equence identity to th~ tlene that we amplified from ~,9 
kb t'raltments of Pst| cut DNA in the present ~tttidy, As 
the two klenes have Identical sequences, but different 
Iocali~a~lonx on human 8enomic DNA. it is concluded 
that tllere are two different copies of the  same 
o~.adrenoceptor gene present in the human itenome, 
It is not presently understood what the physiololliea| 
relevance of the presence of ~everai ¢~a-adrenoceptor 
genes in ti~e genome L'¢, The products of ti~e ¢~=-C2, 
~z.C4 and ~=-CtO llenes, when, expressed in vitro, show 
differin8 =bilities to bind catecholamines and drugs [9]. 
It appears that all these genes are expressed in vivo but 
with grossly dlfferent distributions in the tissues [9- l 1], 
Moreover, a variet~ of functional and ligand binding 
studies have indicated the presence of several phar- 
macololtical subtypes of et=.adrenoceptors with dif- 
ferent distributions in both htunan and animal tissues 
[16-21], Part of  the functional anti binding data is con- 
sistent with the molecular biology data but there are 
also results which indicate that there might possibly ex. 
ist still more species of c~.~.adrenoceptors than those 
already cloned [9]. Moreover, in a recent study it was 
reported that four different mRNAs could be detected 
in Northern blot analysis of rat tissues when 
ctz-adrenoceptor genes were used as probes, possibly 
supporting this contention [22], Very little is presently 
known about the regulation of ~z-adrenergic gene ex- 
pression in vivo. Such information should be of value to 
further tile understanding of the functional importance 
of different ot2-adrenoceptor genes, The elucidation of 
the promoter regions for the c~2-adrenoceptor genes will 
constitute a first step towards the understanding of the 
regulation of their expression. The presence of multiple 
copies of the same c~2-adrenoceptor gene in the human 
genome must be taken into account in such an analysts. 
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